Emma Jones

The FcRn inhibitor rozanolixizumab reduces human serum IgG concentration: A randomized phase 1 study

Rocío Lledó‐García, Shikiko Watanabe, Grant Langdon et al. · Science Translational Medicine · 2017 · 200 citations

Life Sciences, Pharmacology, Pharmacotherapy +17

Effect of therapeutic plasma exchange on immunoglobulins in myasthenia gravis

Jeffrey T. Guptill, Vern C. Juel, Janice M. Massey et al. · Autoimmunity · 2016 · 113 citations · Full text

Life Sciences, Immunology, Internal Medicine +17

Addition of pathology and biomarker information significantly improves the performance of the Manchester scoring system for <i>BRCA1</i> and <i>BRCA2</i> testing

D. Gareth Evans, Fiona Lalloo, Angela Cramer et al. · Journal of Medical Genetics · 2009 · 95 citations · Full text

Medicine, Genetics, Pathology +15

Phase I Study of the JAK2 V617F Inhibitor, LY2784544, in Patients with Myelofibrosis (MF), Polycythemia Vera (PV), and Essential Thrombocythemia (ET)

Srđan Verstovšek, Ruben A. Mesa, Susanne Kloeker Rhoades et al. · Blood · 2011 · 35 citations

Medicine, Hematology, Pharmacology +11

Biosynthesis of the human C3b/C4b receptor during differentiation of the HL-60 cell line. Identification and characterization of a precursor molecule.

John Atkinson, Emma Jones · Journal of Clinical Investigation · 1984 · 32 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +12